Guinea authorities have dissolved dozens of political parties and placed two major opposition ones under observation, while the transitional government has yet to announce an election date DAKAR ...

New Zealand have taken a cautious approach with Kane Williamson by ruling out the key batter from the side's third and final Test against India in Mumbai. Williamson has been battling a groin ...

in combination with Keytruda, Merck’s anti-PD-1 therapy, as adjuvant treatment for patients with resectable Stage II, IIIA or IIIB non-small cell lung cancer who did not achieve a pathological ...

The INTerpath-009 trial will investigate an individualized neoantigen therapy plus Keytruda in patients with non-small cell lung cancer post-surgery whose disease didn't fully respond to prior ...

NEW YORK – Moderna and Merck will test their personalized neoantigen cancer vaccine V940 with Merck's checkpoint inhibitor Keytruda (pembrolizumab) in certain non-small cell lung cancer patients in a ...

Keegan-Michael Key has a ton of options when it comes to picking a favorite Key & Peele sketch. But he has a clear winner — and Halloween is the time to revisit it. “It's such a silly sketch ...

If you want to know where and how you can watch many of the new and recent movies streaming, then you’ve come to the right place. With so many great releases on the 2024 movie schedule, it was ...

Merck, known as MSD outside of the United States and Canada, announced that the European Commission (EC) has approved two new indications for Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in ...

Highlights,Merck gains two new EU approvals for KEYTRUDA in gynecologic cancers.,Approvals cover treatments for advanced endometrial and cervical cancers.,Clinical trials show significant benefits in ...

RAHWAY, N.J. - Merck, known as MSD outside the United States and Canada, has received approval from the European Commission (EC) for two new indications of its anti-PD-1 therapy, KEYTRUDA® ...